Evidence map›Paper›PMID 31793879›Full record

ArticleeLife2019

Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo.

King Faisal Yambire, Christine Rostosky, Takashi Watanabe, David Pacheu-Grau, Sylvia Torres-Odio, Angela Sanchez-Guerrero, Ola Senderovich, Esther G Meyron-Holtz, Ira Milosevic, Jens Frahm and 2 more

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed.

  1. HIV-1 gp120-induced lysosomal stress responses are controlled by TRPML1 redox sensors.Redox report : communications in free radical research · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Autophagy-lysosomal pathway in neurodegeneration.Molecular neurodegeneration advances · 2026
    Review
  12. Article
  13. Vacuolar-type HNature communications · 2025
    Article
  14. Nanomedicines Against Mitochondrial Dysfunction-Induced Metabolic Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

King Faisal YambireInstitute of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany.
Christine RostoskyEuropean Neuroscience Institute, a Joint Initiative of the Max-Planck Institute and of the University Medical Center Goettingen, Goettingen, Germany.
Takashi WatanabeBiomedizinische NMR, Max-Planck Institute for Biophysical Chemistry, Goettingen, Germany.
David Pacheu-GrauInstitute of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany.
Sylvia Torres-OdioDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Austin, United States.
Angela Sanchez-GuerreroInstitute of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany.
Ola SenderovichFaculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Haifa, Israel.
Esther G Meyron-HoltzFaculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Haifa, Israel.
Ira MilosevicEuropean Neuroscience Institute, a Joint Initiative of the Max-Planck Institute and of the University Medical Center Goettingen, Goettingen, Germany.ORCID 0000-0001-6440-3763
Jens FrahmBiomedizinische NMR, Max-Planck Institute for Biophysical Chemistry, Goettingen, Germany.ORCID 0000-0002-8279-884X
A Phillip WestDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Austin, United States.
Nuno RaimundoInstitute of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany.ORCID 0000-0002-5988-9129

Funding

Deutsche Forschungsgemeinschaft Emmy Noether awardDeutsche Forschungsgemeinschaft SFB1190-P02H2020 European Research Council 337327
6 · The paper itself

Abstract

Lysosomal acidification is a key feature of healthy cells. Inability to maintain lysosomal acidic pH is associated with aging and neurodegenerative diseases. However, the mechanisms elicited by impaired lysosomal acidification remain poorly understood. We show here that inhibition of lysosomal acidification triggers cellular iron deficiency, which results in impaired mitochondrial function and non-apoptotic cell death. These effects are recovered by supplying iron via a lysosome-independent pathway. Notably, iron deficiency is sufficient to trigger inflammatory signaling in cultured primary neurons. Using a mouse model of impaired lysosomal acidification, we observed a robust iron deficiency response in the brain, verified by in vivo magnetic resonance imaging. Furthermore, the brains of these mice present a pervasive inflammatory signature associated with instability of mitochondrial DNA (mtDNA), both corrected by supplementation of the mice diet with iron. Our results highlight a novel mechanism linking impaired lysosomal acidification, mitochondrial malfunction and inflammation in vivo.

Indexed as

Iron DeficienciesAcidsalpha-GlucosidasesAnimalsApoptosisBrainCell HypoxiaCell ProliferationDisease Models, AnimalDNA, MitochondrialElectron TransportEnzyme InhibitorsGene Expression RegulationHomeostasisHydrogen-Ion ConcentrationHypoxia-Inducible Factor 1, alpha SubunitAcidsalpha-GlucosidasesDNA, MitochondrialEnzyme InhibitorsHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitIronVacuolar Proton-Translocating ATPasesacidificationbraincell biologyhumanhuman biologyinflammationironlysosomemedicinemitochondriamouse

Identifiers

PMID31793879
PMCPMC6917501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.